
Vaccines Remain Effective against BA.2, but Protection from Infection Wanes over Time
Such protection declines within months of the mRNA COVID vaccines’ third dose. Yet the vaccines continue to ward off severe disease

Vaccines Remain Effective against BA.2, but Protection from Infection Wanes over Time
Such protection declines within months of the mRNA COVID vaccines’ third dose. Yet the vaccines continue to ward off severe disease

People Are Getting COVID Shots Despite Hesitation
Recent findings blow up assumptions about who chooses to get vaccinated against the disease


These Vaccines May Be Ready to Take On New COVID Variants
Novel types of jabs could enhance T-cell immunity or protect against emerging strains

Tracking Outbreaks through Sewers, and Kids’ Vaccines on Hold Again: COVID Quickly, Episode 24
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.
You can listen to all past episodes here.

COVID Vaccines Can Be Safe for People with Prior Allergic Reactions
My colleagues and I use a protocol to inoculate safely, and the CDC needs to revise its recommendations

How Many COVID Vaccine Boosters Will We Need?
Endless boosting might not be a practical or sustainable strategy, scientists say

COVID Quickly, Episode 22: Colds Build COVID Immunity and the Omicron Vaccine Delay
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.
You can listen to all past episodes here.

What’s Holding Up New Omicron Vaccines?
Vaccine makers worry yet another variant will start dominating in the months it takes to roll out shots against this one

A COVID Vaccine for All
With proved technology and no-frills tech transfer, CORBEVAX is poised to reach hundreds of millions in the coming weeks

COVID Quickly, Episode 21: Vaccines against Omicron and Pandemic Progress
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.
You can listen to all past episodes here.

The Risk of Vaccinated COVID Transmission Is Not Low
After my son got sick, I dived into the data, and it turns out vaccinated people can and do spread COVID

Omicron Is Likely to Weaken COVID Vaccine Protection—but Boosters Could Restore It
The rapid spread of new variants such as Omicron offers clues to how SARS-CoV-2 is adapting and how the pandemic will play out over the next several months